Adverse event [GxP / QC / QA]

posted by Bhavesh – India, 2009-08-17 09:41 (6153 d 23:09 ago) – Posting: # 4050
Views: 7,130

Dear KK,

I agree with you but confusion arise during report preparation. Under which treatment I shall consider it. because we specify AE in percentage respective of treatment and based on that final conclusion will drawn.

Bhavesh Shah


Edit: Full quote removed. Please delete anything from the text of the original poster which is not necessary in understanding your answer; see also this post! [Helmut]

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,570 registered users;
103 visitors (0 registered, 103 guests [including 16 identified bots]).
Forum time: 08:51 CEST (Europe/Vienna)

Competence, like truth, beauty and contact lenses,
is in the eye of the beholder.    Laurence J. Peter

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5